Abstract Virtual screening of novel entry inhibitor scaffolds mimicking primary receptor CD4 of HIV-1 gp120 was carried out in conjunction with evaluation of their potential inhibitory activity by molecular modeling. To do this, pharmacophore models presenting different sets of the hotspots of cellular receptor CD4 for its interaction with gp120 were generated. These models were used as the templates for identification of CD4-mimetic candidates by the pepMMsMIMIC screening platform. Complexes of these candidates with gp120 were built by high-throughput ligand docking and their stability was estimated by molecular dynamics simulations and binding free energy calculations. As a result, five top hits that exhibited strong attachment to the two well-conserved hotspots of the gp120 CD4-binding site were selected for the final analysis. In analogy to CD4, the identified compounds make hydrogen bonds with Asp-368gp120 and multiple van der Waals contacts with the gp120 residues that bind to Phe-43CD4, resulting in destruction of the critical interactions of gp120 with Phe-43CD4 and Arg-59CD4. The complexes of the CD4-mimetic candidates with gp120 show relative conformational stability within the molecular dynamics simulations and expose the high percentage occupancies of intermolecular hydrogen bonds, in line with the data on the binding free energy calculations. In light of these findings, the identified compounds are considered as good scaffolds for the development of new functional antagonists of viral entry with broad HIV-1 neutralization.
hotspots            0.9992845385984878^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(Wi-Fi)       

hydrogen bonds                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

molecular modeling            0.9999306727095462^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Computational_chemistry

screening                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

screening                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

Asp                           0.9999999964682047^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Aspartic_acid         

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

scaffolds                     0.9999999997294253^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scaffolding           

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

entry inhibitor               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Entry_inhibitor       

final analysis                0.9999999791932626^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Final_Analysis        

intermolecular                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Intermolecular_force  

inhibitory                    0.9999856898341073^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Enzyme_inhibitor      

analogy                       0.9999999528147339^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Analogy               

neutralization                0.961893329495059^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Neutralisation_(immunology)

free energy calculations      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Gibbs_free_energy     

viral entry                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Viral_entry           

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

high-throughput               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/High-throughput_screening

HIV-1                         0.9999756745650625^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subtypes_of_HIV       

residues                      0.9999999999940883^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Amino_acid            

light                         0.9996927133969261^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Light                 

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

pharmacophore                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Pharmacophore         

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

mimetic                       0.4466646382929538^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mimesis               

molecular dynamics            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Molecular_dynamics    

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

ligand docking                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Docking_(molecular)   

HIV-1                         0.9999756745650625^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Subtypes_of_HIV       

binding site                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Binding_site          

scaffolds                     0.9999999997294253^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Scaffolding           

mimetic                       0.4466646382929538^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Mimesis               

receptor                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_(biochemistry)

CD4                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/CD4                   

cellular receptor             1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_(biochemistry)

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

attachment                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Virus                 

occupancies                   0.9999993701123623^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Occupancy             

hits                          0.6809999187938897^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Web_analytics         

Phe                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phenylalanine         

gp120                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Envelope_glycoprotein_GP120

van der Waals                 0.9999999972175146^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Van_der_Waals_force   

hydrogen bonds                1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Hydrogen_bond         

Arg                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Arginine              

hotspots                      0.9992845385984878^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Hotspot_(Wi-Fi)       

Phe                           1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Phenylalanine         

antagonists                   1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Receptor_antagonist   

